(AMTX) Aemetis - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00770K2024
AMTX: Renewable Natural Gas, Ethanol, Biodiesel, Animal Feed, Biofuels
Aemetis, Inc. is a leader in the production of renewable natural gas (RNG) and low-carbon renewable fuels. The company operates through three primary business segments: California Ethanol, California Dairy RNG, and India Biodiesel. Its core focus is on developing and commercializing advanced technologies to produce renewable fuels with low or negative carbon intensity, designed to replace traditional fossil-based products. Aemetis produces and sells ethanol, wet distillers grains, distillers corn oil, and condensed distillers solubles, primarily to dairies and feedlots as animal feed. Additionally, the company markets USP alcohol and hand sanitizer and produces RNG from dairy waste and biodiesel from vegetable oils and animal waste feedstocks. Aemetis also invests in R&D to convert waste materials into biofuels and biochemicals. Its biodiesel products are sold predominantly to government-owned oil marketing companies. Headquartered in Cupertino, California, the company is at the forefront of the renewable energy transition.
Aemetis is strategically positioned to capitalize on growing demand for renewable energy solutions. The companys California-based operations include ethanol production facilities and RNG projects, while its India segment focuses on biodiesel manufacturing. Aemetis has also expanded into the production of carbon-negative fuels, leveraging its proprietary technologies to convert waste feedstocks into high-value products. The companys commitment to sustainability and innovation has earned it recognition in the renewable fuels sector, with a strong emphasis on reducing greenhouse gas emissions and compliance with global carbon standards.
Looking ahead, Aemetis is expected to continue its expansion into RNG and advanced biofuels. The company has announced plans to scale up production capacity and explore new markets for its renewable products. With a focus on decarbonization and energy security, Aemetis is well-positioned to benefit from increasing regulatory support for renewable fuels and growing demand for sustainable energy solutions.
Additional Sources for AMTX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AMTX Stock Overview
Market Cap in USD | 86m |
Sector | Energy |
Industry | Oil & Gas Refining & Marketing |
GiC Sub-Industry | Oil & Gas Refining & Marketing |
IPO / Inception | 2014-05-15 |
AMTX Stock Ratings
Growth 5y | 14.8% |
Fundamental | 15.7% |
Dividend | 0.0% |
Rel. Strength Industry | -48.3 |
Analysts | 3.67/5 |
Fair Price Momentum | 1.38 USD |
Fair Price DCF | - |
AMTX Dividends
No Dividends PaidAMTX Growth Ratios
Growth Correlation 3m | -93.9% |
Growth Correlation 12m | -69% |
Growth Correlation 5y | -15.7% |
CAGR 5y | 27.37% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | -1.16 |
Alpha | -74.01 |
Beta | 3.43 |
Volatility | 95.41% |
Current Volume | 953.9k |
Average Volume 20d | 808k |
As of March 16, 2025, the stock is trading at USD 1.68 with a total of 953,925 shares traded.
Over the past week, the price has changed by -3.45%, over one month by -18.05%, over three months by -42.47% and over the past year by -47.50%.
Neither. Based on ValueRay Fundamental Analyses, Aemetis is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMTX as of March 2025 is 1.38. This means that AMTX is currently overvalued and has a potential downside of -17.86%.
Aemetis has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold AMTX.
- Strong Buy: 2
- Buy: 1
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, AMTX Aemetis will be worth about 1.5 in March 2026. The stock is currently trading at 1.68. This means that the stock has a potential downside of -10.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 13.9 | 729.8% |
Analysts Target Price | 11.8 | 599.4% |
ValueRay Target Price | 1.5 | -10.7% |